Search the Newsreel

Alpha Cognition Inc (ACOG) - Tradingkey Stock Score & Comprehensive Stock Analysis

Alpha Cognition Inc (ACOG) demonstrates healthy fundamentals and high growth potential, with its valuation considered fairly priced within the Pharmaceuticals industry. The stock has high institutional ownership and multiple analysts rate it as a "Buy" with an upside potential to $16.00. While the company …

Notice to Long-Term Shareholders of Cogent Communications

Grabar Law Office is investigating potential claims on behalf of long-term shareholders of Cogent Communications Holdings, Inc. (CCOI), EquipmentShare.com, Inc. (EQPT), Photronics, Inc. (PLAB), and PROCEPT BioRobotics Corporation (PRCT). The investigations concern alleged breaches of fiduciary duties by officers and directors, including misleading statements, …

Cognizant to Report Q2 Earnings: What's in Store for the Stock?

Cognizant Technology Solutions CTSH is scheduled to report its second-quarter 2026 results on July 29, 2026. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $1.38 per share, which has been unchanged over the past 30 days. This represents a 5.34% increase …

The Andover Companies Selects Cognizant to Modernize Technology and Advance AI-Driven Innovation

198-year-old mutual property and casualty insurer to optimize core systems, unify its data and advance responsible AI adoption under a five-year partnership TEANECK, N.J., July 27, 2026 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) announced today a strategic, five-year, enterprise-wide partnership with The Andover Companies, Inc., …

Cognition Therapeutics Inc (CGTX) Balance Sheet

This article provides the quarterly and annual balance sheets for Cognition Therapeutics Inc (CGTX), offering detailed financial data for various assets, liabilities, and shareholder equity components. It also includes an FAQ section that defines key balance sheet metrics and answers specific questions about CGTX's …

CCOI DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Cogent Investors of Securities Class Action Lawsuit Deadline on September 21, 2026

Faruqi & Faruqi, LLP is reminding investors of Cogent Communications Holdings, Inc. (CCOI) about the September 21, 2026, deadline to seek lead plaintiff status in a federal securities class action lawsuit. The lawsuit alleges that Cogent and its executives made false and misleading statements …

Precision Trading with Cognex Corporation (CGNX) Risk Zones

This article analyzes Cognex Corporation (CGNX), highlighting weak near and mid-term sentiment but a strong long-term outlook. It presents three AI-generated trading strategies: Long Position, Momentum Breakout, and Risk Hedging, with specific entry, target, and stop-loss zones. The analysis emphasizes risk-reward ratios and multi-timeframe …

Alpha Cognition Inc (ACOG) Cash Flow

This article provides a detailed overview of Alpha Cognition Inc's (ACOG) cash flow statements, including operating, investing, and financing activities. It presents quarterly and annual financial figures, along with year-over-year percentage changes for various cash flow components. The report also includes an FAQ section …

Cognition Therapeutics Inc (CGTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Cognition Therapeutics Inc (CGTX) stock, detailing its performance based on various indicators and moving averages. It highlights the current sell and neutral signals from indicators like MACD and RSI, and predominantly sell signals from moving averages. The …

Alpha Cognition Inc (ACOG) Balance Sheet

This article provides the quarterly and annual balance sheets for Alpha Cognition Inc (ACOG), allowing users to evaluate the company's financial health, analyze fundamentals, and calculate key financial ratios. It details assets, liabilities, and shareholders' equity over several periods, and includes an FAQ section …

CCOI Class Action Reminder: Robbins LLP Reminds Investors

Robbins LLP is reminding investors of the lead plaintiff deadline in a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI). The lawsuit alleges that Cogent made false and misleading statements regarding its optical wavelength "backlog," customer demand, financial capacity, and dividend policy, …

Cognizant and Anthropic expand partnership to embed Claude in Cognizant's industry platforms, helping clients close the gap between AI promise and business outcomes

As a Global Premier Partner in the Claude Partner Network, Cognizant brings the industry depth and delivery scale to take Claude from enterprise AI pilots to results in production Cognizant is embedding Claude across its own business and engineering platforms, while scaling a Claude-certified …

Cognex Corp (CGNX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Cognex Corp (CGNX), identifying its major institutional investors and their proportional holdings. It also breaks down shareholder types, institutional shareholding trends over recent quarters, and lists related ETFs that include CGNX in their portfolios.

Cogent Communications Holdings Inc (CCOI) Income Statement

This article presents the quarterly and annual income statements for Cogent Communications Holdings Inc (CCOI), detailing financial performance metrics such as total revenue, cost of revenue, operating expenses, operating profit, and net income. It allows users to analyze the company's operational efficiency and highlights …

Cambridge Cognition reports 16% revenue growth in first half By Investing.com

Cogent Biosciences, Inc. $COGT Shares Bought by SummitTX Capital L.P.

Sona Asset Management US LLC Decreases Position in Cogent Biosciences, Inc. $COGT

What's Going On With Cogeco Communications Inc Stock Monday?

Alpha Cognition Inc (ACOG) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides a financial overview of Alpha Cognition Inc (ACOG), focusing on its dividend and stock split history. It states that the company has distributed $0.00 in dividends over the past five years, indicating no recent dividend payouts. Key financial data like market …

Cogent Biosciences Inc (COGT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for Cogent Biosciences Inc (COGT). It notes that relevant revenue data by business segment and region for FY2021 has not yet been disclosed by the company, though it lists the United States as a region with …

Cognition Therapeutics Inc (CGTX) Income Statement

This article provides the quarterly and annual income statements for Cognition Therapeutics Inc (CGTX), offering detailed financial data such as operating expenses, R&D expenses, operating profit, and net income. It allows for analysis of the company's financial performance and operational efficiency over various periods. …

Cognex Corp (CGNX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article details the historical dividend payouts for Cognex Corp (CGNX), including specific dates for ex-dividend, record, and payment. Over the past five years, the company has distributed a total of $190.59 million in dividends. The information provided outlines interim and final cash dividends …

Alpha Cognition Inc (ACOG) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Alpha Cognition Inc (ACOG), listing its major shareholders and their respective proportions. It also provides a breakdown of shareholder types, institutional holdings over several quarters, and recent shareholder activity with changes in shares held and proportions.

Cognition Therapeutics, Inc. Revenue Breakdown – NASDAQ:CGTX

ACOG|Alpha Cognition Inc|Price:7.900|Chg%:-0.330

Alpha Cognition Inc. (ACOG) closed at $7.90, down 4.01%, with a market cap of $172.02M. The company, focused on neurodegenerative disease treatments, is rated "Buy" by analysts with a target price of $16.00, representing a 94.41% upside. Its fundamentals are strong, and its valuation …

Cogent Communications Holdings Inc Revenue Breakdown – TRADEGATE:OGM1

This article provides a revenue breakdown for Cogent Communications Holdings Inc (OGM1:TRADEGATE). The company generated €830.79 million last year, with its On-net segment being the top performer at €452.54 million. North America was the largest regional contributor, accounting for €697.76 million.

Cogent Communications Holdings Inc (CCOI) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Cogent Communications Holdings Inc (CCOI), detailing its current earnings forecast score, average price target, and analyst ratings. It also includes peer comparisons and answers frequently asked questions regarding expected revenue, price targets, and past EPS performance. The …

Cogent Biosciences Inc (COGT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Cogent Biosciences Inc.'s (COGT) shareholder structure, including major shareholders, shareholder types by proportion, and institutional holdings over several quarters. It lists top institutional investors like Fidelity, BlackRock, and Deerfield Management, alongside their proportional holdings and changes. The …

CGTX|Cognition Therapeutics Inc|Price:0.929|Chg%:+0.010

Cognition Therapeutics Inc. (CGTX) is a clinical-stage biopharmaceutical company focused on developing small molecule therapeutics for age-related degenerative disorders of the central nervous system and retina. The company's lead candidate, zervimesine (CT1812), is in clinical programs for dementia with Lewy bodies (DLB) and Alzheimer’s …

Cognex Corporation Revenue Breakdown – NASDAQ:CGNX

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Cogent Communications Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CCOI

NEW YORK, July 25, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Cogent Communications Holdings, Inc. (NASDAQ: CCOI) between February 29, 2024 and May 1, …

COGENT COMMUNICATIONS HOLDINGS, INC. (CCOI) INVESTOR ALERT Investors With Large Losses in Cogent Communications Holdings, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Bernstein Liebhard LLP has announced a securities class action lawsuit against Cogent Communications Holdings, Inc. (CCOI) on behalf of investors who purchased common stock between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent made materially false and misleading statements, leading …

COGT|Cogent Biosciences Inc|Price:39.760|Chg%:-0.480

Cogent Biosciences Inc. (COGT) closed at $39.76, down 1.19%. The company has strong fundamentals and high growth potential, with its valuation considered fairly priced within the Biotechnology & Medical Research industry. Analysts currently rate the stock as a "Buy" with a target price of …

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Cogent Communications Holdings, Inc. (CCOI)

NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Columbia on behalf of all persons or entities who purchased or otherwise …

Rosen Law Firm Urges Cogent Communications Holdings, Inc. (NASDAQ: CCOI) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

The Rosen Law Firm has announced a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) on behalf of investors who purchased shares between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent made false statements regarding its optical wavelength …

Alpha Cognition Inc. (ACOG) sees 200,086-share buy by 10% holder

Opaleye Management Inc., a ten percent owner of Alpha Cognition Inc. (ACOG), indirectly purchased a total of 200,086 common shares on July 22–23, 2026. These shares were acquired for Opaleye, L.P. and a separately managed account at weighted average prices of $7.8337 and $7.7953 …